What is the current stock price of AdvisorShares Psychedelics ETF (PSIL)?

As of the latest market data, AdvisorShares Psychedelics ETF (PSIL) is trading at $18.76. The stock has seen a gain of 0.78% today.

Does AdvisorShares Psychedelics ETF (PSIL) pay a dividend?

Based on current data, AdvisorShares Psychedelics ETF does not have a confirmed active dividend policy.

What is the market cap of AdvisorShares Psychedelics ETF?

The current market capitalization of AdvisorShares Psychedelics ETF (PSIL) is approximately unavailable.

PSIL

AdvisorShares Psychedelics ETF·Financial Services

18.76

0.780%(+0.15)

Market Closed

22.99

22.580%(+4.23)

After Hours

Last Updated: — ET

52W L: $10.6052W H: $21.61

PSIL NEWS

newsfilecorp.com

4d ago

Pacifica Silver Reports Initial Phase II Drill Results at Claudia with Multiple High-Grade Intercepts at the Aguilareña Area

Vancouver, British Columbia--(Newsfile Corp. - April 14, 2026) - Pacifica Silver Corp. (CSE: PSIL) (OTCQB: PAGFF) ("Pacifica Silver" or the "Company") is pleased to announce assay results from the first 16 holes of its Phase II, 20,000-metre diamond drilling program at the 100% owned Claudia Silver-Gold Project ("Project") located in the historic El Papantón Mining District in Durango State, Mexico. Fourteen of the 16 holes successfully intersected silver-gold mineralization, including multiple high-grade intercepts.

newsfilecorp.com

Apr 9

Pacifica Silver Announces Adoption of Semi-Annual Reporting

Vancouver, British Columbia--(Newsfile Corp. - April 9, 2026) - Pacifica Silver Corp. (CSE: PSIL) (OTCQB: PAGFF) ("Pacifica Silver" or the "Company") announces that it has adopted a semi-annual financial reporting ("SAR") framework, effective immediately. This change is being made pursuant to British Columbia Securities Commission Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers ("CBO 51-933").

newsfilecorp.com

Apr 2

Pacifica Silver Provides Exploration Update at Claudia Silver-Gold Project; Grants Incentive Stock Options

Vancouver, British Columbia--(Newsfile Corp. - April 2, 2026) - Pacifica Silver Corp. (CSE: PSIL) (OTCQB: PAGFF) ("Pacifica" or the "Company") is pleased to provide an update on exploration activities at its 100% owned Claudia Silver-Gold Project located in Durango State, Mexico. Recent assay results from 286 surface channel samples collected in late 2025 and early 2026 have enabled the Company to identify and commence drill testing of two new high-priory targets at the Pinolera zone and recently recognized Contraria vein swarm.

feeds.benzinga.com

Mar 16

NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug

The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.

newsfilecorp.com

Mar 16

Pacifica Silver Expands Phase II Drill Program at Claudia to 20,000 m; Appoints Dr. Steven I. Weiss as Interim VP Exploration

Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Pacifica Silver Corp. (CSE: PSIL) (OTCQB: PAGFF) ("Pacifica" or the "Company") is pleased to announce the expansion of its Phase II drill program from 12,000 to 20,000 metres at the Claudia Silver-Gold Project, located in Durango, Mexico. The Company also announces the appointment of Steven I.

newsfilecorp.com

Feb 18

Pacifica Silver Reports Additional Drill Results at Claudia with Multiple High-Grade Silver-Gold Intercepts at the Aguilareña Area

Vancouver, British Columbia--(Newsfile Corp. - February 18, 2026) - Pacifica Silver Corp. (CSE: PSIL) (OTCQB: PAGFF) ("Pacifica Silver" or the "Company") is pleased to announce assay results from the remaining nine holes of its Phase I diamond drilling program at the 100% owned Claudia Silver-Gold Project ("Project") located in the historic El Papantón Mining District in Durango State, Mexico. The Phase I program, comprising 30 holes for approximately 8,000 metres, was successfully completed in late December 2025, with initial results previously reported in news releases dated December 15, 2025, and February 9, 2026.

Company Profile

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Sector

Financial Services

Industry

Asset Management

IPO Date

2021-09-16

Beta

0.38

Websiteadvisorshares.com/etfs/psil↗